EchoLaser® ablation of multiple uterine leiomyomas: a case report

Uterine leiomyomas are common benign tumors of the female genital tract, found in nearly every fourth woman of reproductive age [1]. While leiomyomas are mostly asymptomatic, some
may produce various clinical symptoms, such as abnormal menstrual bleeding, pelvic pressure symptoms or pain, infertility and obstetric complications [2]. Currently, the most suitable surgical
option for women with uterine leiomyomas, who want to retain their fertility, is myomectomy, whether hysteroscopic, laparoscopic or open. However, myomectomy is a relatively extensive
procedure which poses a risk of various complications (uterine rupture, bleeding, incomplete resection, etc.) and its effects on reproductive function remain controversial.

EchoLaser® is a new device for ultrasound-guided micro-invasive treatments. This is the first and only laser system integrated with a navigation, planning and simulation system. EchoLaser®
consists of an ultrasound probe and a multi-source laser (up to 4 sources); thanks to the incorporation of the ultrasound, the device can be used for both identification of the lesions and
real-time monitoring of the correct positioning of laser fibers and the actual extent of the damage caused to the lesion.
Below, we present the case of a patient with multiple uterine leiomyomas ablated with EchoLaser®. To the best of our knowledge, this is the first published report documenting the
successful application of EchoLaser® in this indication.

Case Report
A 42-year-old premenopausal woman was referred to the clinic on 30 November 2019, with multiple uterine leiomyomas found on ultrasound by a local practitioner. The patient complained
about a recurrent pelvic pain without vaginal bleeding. A screening test for cervical cancer performed eight months earlier showed no abnormalities. Ultrasound examination carried out on
admission revealed two intramural uterine leiomyomas with an overall size of 75 mm x 56 mm x 56 mm. Because the patient did not exclude further reproductive plans and based on the clinical and
ultrasonographic presentation of the lesion, the woman was qualified for EchoLaser® ablation. The procedure was carried out on 18 December 2019 at EMC Clinic in Wroclaw (Poland).
After the introduction of spinal anesthesia with bupivacaine hydrochloride (Maracain Heavy 0.5%, 4 ml), the two leiomyomas were localized by the operator (Dr. Tomasz Sędziak) under ultrasound
guidance and ablated with two long fibers of EchoLaser® (1,600 J each). The entire procedure lasted 30 minutes. Neither bleeding nor other periprocedural complications were recorded.

Developed by DMSc Tomasz Sędziak



    Start typing and press Enter to search

    Personal data protection

    Our website uses cookies. By using the site, you agree to their recording or reading in accordance with the browser settings.More information

    I agree